ReviewCurrent reviews in musculoskeletal medicine2026
The Current State of Anterior Cruciate Ligament Reconstruction: Graft Selection, Lateral Augmentation, Rehabilitation, and Return-to-Play.
Review in Current reviews in musculoskeletal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewAnterior cruciate ligament reconstruction (ACLR) reliably restores anteroposterior stability; however, the rate of return to prior level of play and incidence of recurrent ACL injury have improved little over the past two decades. The purpose of this review is to describe the current state of ACLR with respect to graft selection, lateral extra-articular augmentation, rehabilitation and return to play, including the role of psychological readiness, and the specific rehabilitation protocol utilized by the senior author. RECENT
findingsGraft utilization has shifted substantially. Quadriceps tendon autograft accounted for less than 5% of primary reconstructions prior to 2014 and approximately 20% by 2023. Contemporary registry data demonstrate smaller differences in revision risk between autograft types than previously reported. Randomized and comparative data support lateral extra-articular tenodesis in selected high-risk knees, with the largest effect reported in the revision setting. Return-to-play practice has shifted from fixed timelines toward criteria-based clearance. However, a subset of athletes do not pass a full clearance battery, and some athletes who do pass and observe recommended timeframes still sustain reinjury. Limb symmetry index may overestimate functional recovery, while test batteries and thresholds vary considerably between institutions. Psychological readiness is independently associated with both return to sport and second ACL injury. Graft selection should be matched to the patient profile, and lateral augmentation should be reserved for high-risk knees. Return to play should be determined by a combination of time from surgery, functional criteria, and psychological readiness. Future study should focus on validating return-to-play criteria against reinjury endpoints and on standardizing how these criteria are defined and reported.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.